Paper40333329
Intranasal Sendai Virus Vaccination of Seropositive Children 1 to 2 Years of Age in a Phase I Clinical Trial Boosts Immune Responses Toward Human Parainfluenza Virus Type 1.
Adderson E and 11 others. Vaccines (Basel), 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Intranasal Sendai Virus Vaccination of Seropositive Children 1 to 2 Years of Age in a Phase I Clinical Trial Boosts Immune Responses Toward Human Parainfluenza Virus Type 1. Papers, record 40333329. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40333329
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Intranasal Sendai Virus Vaccination of Seropositive Children 1 to 2 Years of Age in a Phase I Clinical Trial Boosts Immune Responses Toward Human Parainfluenza Virus Type 1.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 AI031596 | NIAID NIH HHS | United States | P01AI031596 | PubMed and NIH | NIH RePORTER |
| P01 AI054955 | NIAID NIH HHS | United States | P01AI054955 | PubMed and NIH | NIH RePORTER |
| R01 AI088729 | NIAID NIH HHS | United States | R01AI088729 | PubMed and NIH | NIH RePORTER |
| R21 AI056974 | NIAID NIH HHS | United States | R21AI056974 | PubMed and NIH | NIH RePORTER |
| R34 AI081875 | NIAID NIH HHS | United States | R34AI081875 | PubMed and NIH | NIH RePORTER |
| P30 CA021765 | NCI NIH HHS | United States | P30CA021765 | PubMed | NIH RePORTER |
| ALSAC | American Lebanese Syrian Associated Charities | PubMed | PubMed |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00186927 | A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and Toddlers | Derived from the trial | Yes |
Source ClinicalTrials.gov
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6304611 | Croup: an 11-year study in a pediatric practice. | Pediatrics | 1983 | https://conductscience.org/library/papers/6304611 | PubMed |
| 2 | 37436413 | [Intranasal vaccine against COVID-19 based on a recombinant variant of the Sendai virus (Paramyxoviridae: Respirovirus) strain Moscow]. | Vopr Virusol | 2023 | https://conductscience.org/library/papers/37436413 | PubMed |
| 3 | 26908486 | Estimates of Parainfluenza Virus-Associated Hospitalizations and Cost Among Children Aged Less Than 5 Years in the United States, 1998-2010. | J Pediatric Infect Dis Soc | 2016 | https://conductscience.org/library/papers/26908486 | PubMed |
| 4 | 38543921 | Reduction in Interferon-Stimulated Genes Contributes to High-Yield Production of Influenza Virus in Suspension MDCK Cells. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/38543921 | PubMed |
| 5 | 12029153 | Primary replication of a recombinant Sendai virus vector in macaques. | J Gen Virol | 2002 | https://conductscience.org/library/papers/12029153 | PubMed |
| 6 | 18508560 | Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen. | Front Biosci | 2008 | https://conductscience.org/library/papers/18508560 | PubMed |
| 7 | 14449901 | Growth characteristics of monkey kidney cell strains LLC-MK1, LLC-MK2, and LLC-MK2(NCTC-3196) and their utility in virus research. | J Exp Med | 1962 | https://conductscience.org/library/papers/14449901 | PubMed |
| 8 | 35973352 | The next frontier in vaccine design: blending immune correlates of protection into rational vaccine design. | Curr Opin Immunol | 2022 | https://conductscience.org/library/papers/35973352 | PubMed |
| 9 | 22128250 | The polio-eradication programme and issues of the end game. | J Gen Virol | 2012 | https://conductscience.org/library/papers/22128250 | PubMed |
| 10 | 28133811 | Complex immune correlates of protection in HIV-1 vaccine efficacy trials. | Immunol Rev | 2017 | https://conductscience.org/library/papers/28133811 | PubMed |
| 11 | 20399493 | Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. | Lancet | 2010 | https://conductscience.org/library/papers/20399493 | PubMed |
| 12 | 26850558 | Immunogenicity of a recombinant Sendai virus expressing the capsid precursor polypeptide of foot-and-mouth disease virus. | Res Vet Sci | 2016 | https://conductscience.org/library/papers/26850558 | PubMed |
| 13 | 31786669 | Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines. | J Mol Med (Berl) | 2019 | https://conductscience.org/library/papers/31786669 | PubMed |
| 14 | 4305199 | Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. | Am J Epidemiol | 1969 | https://conductscience.org/library/papers/4305199 | PubMed |
| 15 | 21963661 | Biological feasibility of measles eradication. | Virus Res | 2011 | https://conductscience.org/library/papers/21963661 | PubMed |
| 16 | 219669 | Sendai virus. | Adv Virus Res | 1978 | https://conductscience.org/library/papers/219669 | PubMed |
| 17 | 38543806 | Evaluation of Vaccine Immunogenicity-Correlates to Real-World Protection: Influenza. | Viruses | 2024 | https://conductscience.org/library/papers/38543806 | PubMed |
| 18 | 12082313 | Induction of HIV-1-specific neutralizing antibodies in mice vaccinated with a recombinant Sendai virus vector. | Jpn J Infect Dis | 2002 | https://conductscience.org/library/papers/12082313 | PubMed |
| 19 | 31767462 | Updates on immunologic correlates of vaccine-induced protection. | Vaccine | 2020 | https://conductscience.org/library/papers/31767462 | PubMed |
| 20 | 20682364 | Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1. | Vaccine | 2010 | https://conductscience.org/library/papers/20682364 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42597254 | Insights Into monoclonal antibodies and vaccines targeting respiratory viruses. | Front Pediatr | 2026 | https://conductscience.org/library/papers/42597254 | PubMed |
| 42300833 | High prevalence and clinical impact of microbial co-detection in hospitalized children with human parainfluenza virus type 1. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/42300833 | PubMed |
| 40663463 | Precision engineering of human cytomegalovirus without BAC constraints: a Sendai virus-delivered CRISPR/Cas9 approach. | J Gen Virol | 2025 | https://conductscience.org/library/papers/40663463 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD79A | 973 | PubTator's text mining | https://conductscience.org/library/genes/973 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40333329
GET https://conductscience.org/api/papers/v1/40333329/references?page=2